German Adrenocortical Carcinoma Registry
Launched by UNIVERSITY OF WUERZBURG · Mar 28, 2007
Trial Information
Current as of July 26, 2025
Recruiting
Keywords
ClinConnect Summary
The German Adrenocortical Carcinoma Registry is a clinical trial aimed at improving the care of patients with adrenocortical carcinoma, a rare type of cancer that affects the adrenal glands. The main goal of this registry is to gather information from as many patients as possible to better understand how different treatments work and to help design future studies. By collecting this data, researchers hope to create better treatment plans and improve the overall care for patients with this condition. The registry also collaborates with networks in other countries, such as Italy and France, to enhance therapy options on a larger scale.
If you or a loved one has been diagnosed with adrenocortical carcinoma, you may be eligible to participate in this registry. To join, participants must have a confirmed diagnosis of this type of cancer. Being part of this registry means that your health information will contribute to important research that could benefit current and future patients. While the trial is currently recruiting, it is open to all ages and genders. Participating in the registry does not require any specific treatment changes, but it gives you a chance to help improve cancer care for others.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Histologically confirmed diagnosis of adrenocortical carcinoma
About University Of Wuerzburg
The University of Würzburg, a prestigious institution located in Bavaria, Germany, is renowned for its commitment to advancing medical research and education. With a rich history dating back to 1402, the university is home to a diverse range of interdisciplinary research initiatives, particularly in the fields of medicine, life sciences, and pharmacology. As a clinical trial sponsor, the University of Würzburg is dedicated to conducting innovative research that aims to improve patient outcomes and contribute to the global medical community. The institution emphasizes ethical practices, rigorous scientific methodologies, and collaboration with various stakeholders to ensure the integrity and success of its clinical trials.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Wuerzburg, , Germany
Patients applied
Trial Officials
Martin Fassnacht, MD
Principal Investigator
University of Wuerzburg
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials